US3345270A - Diagnostic composition for isolating and identifying yeasts - Google Patents

Diagnostic composition for isolating and identifying yeasts Download PDF

Info

Publication number
US3345270A
US3345270A US369281A US36928164A US3345270A US 3345270 A US3345270 A US 3345270A US 369281 A US369281 A US 369281A US 36928164 A US36928164 A US 36928164A US 3345270 A US3345270 A US 3345270A
Authority
US
United States
Prior art keywords
yeasts
diagnostic composition
diagnostic
isolating
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US369281A
Inventor
Gray Joseph Edward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Pharmacal Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharmacal Co filed Critical Norwich Pharmacal Co
Priority to US369281A priority Critical patent/US3345270A/en
Application granted granted Critical
Publication of US3345270A publication Critical patent/US3345270A/en
Assigned to NORWICH EATON PHARMACEUTICALS, INC., A CORP. OF OH reassignment NORWICH EATON PHARMACEUTICALS, INC., A CORP. OF OH ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: MORTON-NORWICH PRODUCTS, INC., A CORP. OF DE
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/80—Elimination or reduction of contamination by undersired ferments, e.g. aseptic cultivation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/921—Candida
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/921—Candida
    • Y10S435/922—Candida albicans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/921—Candida
    • Y10S435/924—Candida tropicalis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/94—Saccharomyces
    • Y10S435/942—Saccharomyces cerevisiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/944—Torulopsis

Definitions

  • yeasts as used herein does not imply any taxonomical classification but is employed in the sense of its general usage to designate the organisms with which the present invention is concerned.
  • Still another object of this invention is the provision of a diagnostic medium adapted to encourage the growth of yeasts while suppressing or inhibiting the growth of commonly encountered saprophytic or pathogenic bacteria whose growth tends to obscure and vitiate the characteristic growth and appearance of yeasts.
  • the composition of this invention comprises a mixture of agar, carbohydrate, protein, surfactant, phosphomolybdic acid, an antibacterial agent and water.
  • the agar employed in the preparation of this composition is the commonly used agar-agar derived from certain seaweeds and serves as the solidifying agent.
  • the carbohydrate source is conveniently supplied by sucrose, while the protein requirements are met through the use of proteose-peptone (Difco) and yeast nitrogen base (Difco).
  • the surfactant is preferably of the nonionic type as exemplified by the Tween series (Atlas Chemical Industries).
  • the antibacterial agent may be chosen from those known to exert substantially no eifect upon yeast growth while effectively suppressing bacterial growth. Exemplary of such agents are neomycin, penicillin,
  • the phosphomolybdic acid is that having substantially the formula (Merck). Water is, of course, the major ingredient, serving as a carrier.
  • the diagnostic medium is prepared by combining 5 ml. of (l) with thorough shaking, 1 ml. of (2), 3 ml. of (3) and 5 ml. of (4) with the molten stock medium A.
  • the pH of the diagnostic medium thus prepared is about 5.2. It can be stored until needed by pouring in sealed petri plates or preferably in vials. A 2 dram vial containing about 3.5 ml. of diagnostic medium is preferred since it is readily stored and convenient to use. In storage there is no evidence of deterioration of this medium. Hence, it can be retained and obviates the necessity to make a fresh batch each time occasion arises for its use.
  • Candida tropicalis A deep blue colony Candida albicans var.
  • a sample obtained by a loop or sterile swab is implanted in the diagnostic composition which is maintained at room temperature (2025 C.) for a period of 34 days, after which the characteristics and appearance of the sample are observed and differentiated.
  • a diagnostic composition useful in the rapid and positive identification of yeast species comprising:
  • aqueous solutions consisting of (a) phosphomo-lybdic acid in the proportion of mgs./ 3 ml. H O, (b) polyoxyethylene sorbitan monolaurate in the proportion of 1 ml./ 8.75 ml. H O; (c) yeast nitrogen base in the proportion of 6.7 gm./ ml. H 0 and (d) an antibacterial agent in the proportion of 800 units of penicillin and 2000 mcg. of streptomycin/m1.
  • composition of claim 1 wherein the antibacterial agent is neomycin in the proportion of 10 mg./ml.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Description

United States Patent This invention relates to improvements in diagnostic compositions useful in isolating and identifying yeasts and to methods for employing such compositions for such purpose. The term yeasts as used herein does not imply any taxonomical classification but is employed in the sense of its general usage to designate the organisms with which the present invention is concerned.
In the past decade the increasing appearance of yeasts in pathological conditions has provoked a need for means to isolate, separate, and clearly identify them in order that those concerned therewith may approach their eradication, when desirable or necessary, with maximal certainty and assurance. Failure to recognize the nature of a yeast influencing a pathological condition may result in undue delay and misapplication of proper therapeutic techniques for the relief of such condition. This is, of course, undesirable.
The problem of yeasts, their isolation and identification has not gone unnoticed in the art. Several proposed means aimed at this problem have appeared and have met with some success. Notably, a composition developed by MacLarenet aL'and reported in the Americal Journal of Clinical Pathology, 30: 411-422 (1958) has been used in the art to isolate and distinguish various yeasts. However, this, and other means have not wholly solved the problem.
It is an object of this invention to provide a diagnostic composition having an enhanced capacity to differentiate among closely related yeasts involved in pathologic conditions.
It is another object of this invention to provide diagnostic compositions which are readily prepared and can be stored for long periods without substantial change.
It is still another object of this invention to provide diagnostic compositions which are adapted to be used readily in small tubes as well as the commonly employed petri plate, thus permitting greater facility in isolating and identifying yeasts.
It is a further object of this invention to provide diagnostic compositions adapted to readily discern the presence of mixed cultures.
Still another object of this invention is the provision of a diagnostic medium adapted to encourage the growth of yeasts while suppressing or inhibiting the growth of commonly encountered saprophytic or pathogenic bacteria whose growth tends to obscure and vitiate the characteristic growth and appearance of yeasts.
In accordance with the aforesaid objects the composition of this invention comprises a mixture of agar, carbohydrate, protein, surfactant, phosphomolybdic acid, an antibacterial agent and water. The agar employed in the preparation of this composition is the commonly used agar-agar derived from certain seaweeds and serves as the solidifying agent. The carbohydrate source is conveniently supplied by sucrose, while the protein requirements are met through the use of proteose-peptone (Difco) and yeast nitrogen base (Difco). The surfactant is preferably of the nonionic type as exemplified by the Tween series (Atlas Chemical Industries). The antibacterial agent may be chosen from those known to exert substantially no eifect upon yeast growth while effectively suppressing bacterial growth. Exemplary of such agents are neomycin, penicillin,
streptomycin and the like. The phosphomolybdic acid is that having substantially the formula (Merck). Water is, of course, the major ingredient, serving as a carrier.
The following description is exemplary of the preparation of the composition of this invention:
A. Stock medium Agar (1.5 gms.), sucrose (4.0 gms.) and proteose peptone (1.0 gm.) are added to water ml.) in a suitable vessel which is heated in a water bath until all ingredients are dissolved. The solution is autoclaved at 10 lbs. pressure for 15 minutes and then allowed to harden. It is then remelted in a water bath and then allowed to cool to a molten state (40-50) and held in this state awaiting the addition of other ingredients.
B. Solutions dissolving streptomycin sulfate and potassium penicillin G in' water so that each milliliter contains 2000 mcg. of streptomycin and 800 units of penicillin. In lieu of the penicillin-streptomycin solution, neomycin solution containing 10 mg. of neomycin in each milliliter may be used.
C. Diagnostic medium The diagnostic medium is prepared by combining 5 ml. of (l) with thorough shaking, 1 ml. of (2), 3 ml. of (3) and 5 ml. of (4) with the molten stock medium A.
The pH of the diagnostic medium thus prepared is about 5.2. It can be stored until needed by pouring in sealed petri plates or preferably in vials. A 2 dram vial containing about 3.5 ml. of diagnostic medium is preferred since it is readily stored and convenient to use. In storage there is no evidence of deterioration of this medium. Hence, it can be retained and obviates the necessity to make a fresh batch each time occasion arises for its use.
It is a feature in the preparation of this diagnostic composition that the incorporation of a surfactant abets the introduction of the phosphomolybdic acid into the stock medium A. and also suppresses the tendency to froth formation.
It has been found that when the diagnostic composition of this invention is contacted with various yeasts there is produced a characteristic colony coloration, characteristic colony growth and characteristic pigmentation of the medium. Thus, when yeasts of the genera Candida, Saccharomyces, T orulopsis and Tn'chosporon are exposed to this diagnostic composition at room temperature for a period of from 3-4 days the color of the colony ranges from white to olive to tan to gray to blue having gradation in shade as well as distinctive growth behavior and pigmenting characteristics. These functional diiferences in the presence of the diagnostic composition of this invention enable an identification of yeasts of pathologic concern.
In the table below is presented the behavior of various yeast species in the presence of the composition of this invention:
3 Yeast: Identifying characteristics Candida albicans An olive colony. Candida tropicalis A deep blue colony Candida albicans var.
stellatoidea T orulopsis glabrata A From the foregoing it is apparent that various yeast species react differently in contact with this diagnostic composition producing responses permitting difierentiation. Color production is enhanced due to the presence of the surfactant and bacterial growth suppressed to a noninterfering level by the presence of an antibacterial agent.
In carrying out the practice of this invention a sample obtained by a loop or sterile swab is implanted in the diagnostic composition which is maintained at room temperature (2025 C.) for a period of 34 days, after which the characteristics and appearance of the sample are observed and differentiated. In this way a positive identification of a single yeast organism or of a plurality of such organisms is secured in accordance with the teachings of this invention thus enabling appropriate and direct steps for dealing therewith to be taken.
What is claimed is:
1. A diagnostic composition useful in the rapid and positive identification of yeast species comprising:
Gms. Agar 1.5 Sucrose 4.0 Proteose peptone 1.0
dissolved in 100 ml. of Water and subjected to autoclaving, cooling, and remelting and having dispersed therein aqueous solutions consisting of (a) phosphomo-lybdic acid in the proportion of mgs./ 3 ml. H O, (b) polyoxyethylene sorbitan monolaurate in the proportion of 1 ml./ 8.75 ml. H O; (c) yeast nitrogen base in the proportion of 6.7 gm./ ml. H 0 and (d) an antibacterial agent in the proportion of 800 units of penicillin and 2000 mcg. of streptomycin/m1.
2. The composition of claim 1 wherein the antibacterial agent is neomycin in the proportion of 10 mg./ml.
References Cited UNITED STATES PATENTS 3/1957 Goldman -100 1/1961 Pagano et a1. 195l03.5
OTHER REFERENCES MacLaren et al.: American Journal of Clinical Pathology, vol. 3 0, pages 411-422 (1958).
ALVIN E. TANENHOLTZ, Primary Examiner.
R. R. JONES, Assistant Examiner.

Claims (1)

1. A DIAGNOSTIC COMPOSITION USEFUL IN THE RAPID AND POSITIVE IDENTIFICAION OF YEAST SPECIES COMPRISING:
US369281A 1964-05-21 1964-05-21 Diagnostic composition for isolating and identifying yeasts Expired - Lifetime US3345270A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US369281A US3345270A (en) 1964-05-21 1964-05-21 Diagnostic composition for isolating and identifying yeasts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US369281A US3345270A (en) 1964-05-21 1964-05-21 Diagnostic composition for isolating and identifying yeasts

Publications (1)

Publication Number Publication Date
US3345270A true US3345270A (en) 1967-10-03

Family

ID=23454827

Family Applications (1)

Application Number Title Priority Date Filing Date
US369281A Expired - Lifetime US3345270A (en) 1964-05-21 1964-05-21 Diagnostic composition for isolating and identifying yeasts

Country Status (1)

Country Link
US (1) US3345270A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144133A (en) * 1977-08-25 1979-03-13 J. K. And Susie L. Wadley Research Institute And Blood Bank Fungal growth media
US5270032A (en) * 1990-10-04 1993-12-14 The Research Foundation Of State University Of New York Composition and method for the prevention and treatment of candidiasis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2784146A (en) * 1954-09-16 1957-03-05 Leon S Goldman Growing and identification of fungi
US2968597A (en) * 1957-10-01 1961-01-17 Olin Mathieson Method and composition for detecting candida albicans

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2784146A (en) * 1954-09-16 1957-03-05 Leon S Goldman Growing and identification of fungi
US2968597A (en) * 1957-10-01 1961-01-17 Olin Mathieson Method and composition for detecting candida albicans

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144133A (en) * 1977-08-25 1979-03-13 J. K. And Susie L. Wadley Research Institute And Blood Bank Fungal growth media
US5270032A (en) * 1990-10-04 1993-12-14 The Research Foundation Of State University Of New York Composition and method for the prevention and treatment of candidiasis

Similar Documents

Publication Publication Date Title
EP1390524B1 (en) Staphylococcus aureus specific detection media and identifying and/or counting method using same
Snyder et al. Sodium azide as an inhibiting substance for gram-negative bacteria
EP2344663B1 (en) Reaction medium for staphylococcus aureus bacteria
DE69122385T2 (en) NEW AND IMPROVED METHOD FOR DETERMINING E. COLI IN WATER
DE4316394C1 (en) A method of optically detecting microorganisms, their identification and antibiotic susceptibility testing using a redox indicator system comprising methylene blue and resazurin
JP2001508305A (en) Growth media for selective detection of staphylococci
US3197384A (en) Process for the determination of microbial sensitivity to antimicrobial agents
US3345270A (en) Diagnostic composition for isolating and identifying yeasts
Smith et al. Stability of pleuropneumonialike organisms to some physical factors
DE2717979A1 (en) STAPHYLOCOCCUS AUREUS BROTH
US4857459A (en) Stain for acid-fast bacilli
Collins et al. The action of certain bacteria on some simple tri-glycerides and natural fats, as shown by Nile-blue sulphate
Knaysi A microscopic method of distinguishing dead from living bacterial cells
DE2547622C3 (en) Test set
DE60131187T2 (en) METHOD AND MEDIUM FOR DETECTING / IDENTIFYING MICROORGANISMS WITH ESTERASE ACTIVITY
US2963400A (en) Product and process for prevention and curing of disease in aquarium fish
DE69219734T2 (en) Microbiological analytical environment and method for the detection of yeasts of the species Candida albicans
US5827680A (en) Three reagent gram staining method and kit
Stearn et al. The mechanical behavior of dyes, especially gentian violet, in bacteriological media
DE69837768T2 (en) METHOD AND AGENT FOR DETERMINING DEAMINASE ACTIVITY
WO1999048899A1 (en) Novel potentially fluorogenic compounds
US4217411A (en) Novel enrichments for blood culture media
Richards et al. Preservation of sodium bicarbonate eye lotion BPC against contamination with Pseudomonas aeruginosa.
US4049499A (en) Microbial medium having fluorescent growth indicator
US2798811A (en) Inhibiting micro-biological growth in beer

Legal Events

Date Code Title Description
AS Assignment

Owner name: NORWICH EATON PHARMACEUTICALS, INC., 17 EATON AVE.

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:MORTON-NORWICH PRODUCTS, INC., A CORP. OF DE;REEL/FRAME:004085/0126

Effective date: 19820609